Current strategies in hormonal manipulation of advanced prostate cancer

摘要

Initial treatment choice depends partly on the patient's preference. Tumor models elucidated genetic influence, threshold tissue levels of activity and mechanism of actions. Luteotrope hormone-releasing hormone agonists and antiandrogens are integrated in clinical practice. Imidazole derivations, 5alpha;-reductase blockers and growth-factor antagonists offer clinical potential.